MYC Protein Expression Is Detected in Majority of Multiple Myeloma but Not in Monoclonal Gammopathy of Undetermined Significance (MGUS)

被引：0
|
作者：
Xiao, R. [1 ]
Dresser, K. [1 ]
Woda, B. [1 ]
Yu, H. [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1535
引用
收藏
页码：367A / 367A
页数：1
相关论文
共 50 条
  • [21] Patients With Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance
    Piechotta, Vanessa
    Skoetz, Nicole
    Engelhardt, Monika
    Einsele, Hermann
    Goldschmidt, Hartmut
    Scheid, Christof
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2022, 119 (14): : 253 - +
  • [22] Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
    Kyle, Robert A.
    Rajkumar, S. Vincent
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (02) : 62 - 69
  • [23] Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
    Rajkumar, S. Vincent
    Lacy, Martha Q.
    Kyle, Robert A.
    BLOOD REVIEWS, 2007, 21 (05) : 255 - 265
  • [24] Longitudinal whole body MRI (wbMRI) in monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma
    Merz, Maximilian
    Wagner-Gund, Barbara
    Neben, Kai
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Hillengass, Jens
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)
    Matthew Ho
    Ashish Patel
    Chia Yin Goh
    Maria Moscvin
    Li Zhang
    Giada Bianchi
    Leukemia, 2020, 34 : 3111 - 3125
  • [26] THE PREVALENCE OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) AND ASYMPTOMATIC MULTIPLE MYELOMA (AMM) FOR HIGH RISK GROUPS
    Oner, I.
    Unal, A.
    Pala, C.
    Sivgin, S.
    Keklik, M.
    Patiroglu, T.
    Akyol, G.
    Cetin, M.
    Eser, B.
    HAEMATOLOGICA, 2013, 98 : 613 - 613
  • [27] Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)
    Ho, Matthew
    Patel, Ashish
    Goh, Chia Yin
    Moscvin, Maria
    Zhang, Li
    Bianchi, Giada
    LEUKEMIA, 2020, 34 (12) : 3111 - 3125
  • [28] Genomic aberrations in monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) and the risk of progression to multiple myeloma (MM)
    Van Wier, S. A.
    Larson, D. M.
    Chng, W.
    Rempel, R.
    Ahmann, G. J.
    Henderson, K. M.
    Figueroa, G.
    Kyle, R. A.
    Rajkumar, S. V.
    Dispenzieri, A. D.
    Bersagel, P. L.
    Stewart, A. K.
    Therneau, T. M.
    Greipp, P. R.
    Fonseca, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 99 - 99
  • [29] Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS)
    Caimi, G.
    Hopps, E.
    Carlisi, M.
    Montana, M.
    Galla, E.
    Lo Presti, R.
    Siragusa, S.
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2018, 68 (01) : 51 - 59
  • [30] FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma
    Korac, Petra
    Peran, Ivana
    Skrtic, Anita
    Ajdukovic, Radmila
    Kristo, Delfa Radic
    Dominis, Mara
    PATHOLOGY INTERNATIONAL, 2009, 59 (05) : 354 - 358
12345